Articles | EuroIntervention

10.4244/EIJV8I4A64 • Aug 24, 2012

In pursuit of perfection: “alive and better” as the measure of procedural success

Brennan JM

free

10.4244/EIJV8I4A65 • Aug 24, 2012

Not all drug-eluting balloons are equally good for patients, not all patients are equally suitable for drug-eluting balloons

Cassese S, Kastrati A

free

10.4244/EIJV8I4A66 • Aug 24, 2012

Multivessel versus culprit-only revascularisation in ST elevation acute myocardial infarction: facts and criticism

Kornowski R

free

10.4244/EIJV8I4A67 • Aug 24, 2012

The latest news about the ESCeL Platform

Fajadet J, Gonçalves L, Gilard M

free

10.4244/EIJV8I4A68 • Aug 24, 2012

Quality of life improvement is maintained up to two years after transcatheter aortic valve implantation in high-risk surgical candidates

Taramasso M, Latib A, Cioni M, Denti P, Buzzatti N, Godino C, Chieffo A, Alfieri O, Colombo A, Maisano F

free

10.4244/EIJV8I4A69 • Aug 24, 2012

Improvement of physical and mental health after transfemoral transcatheter aortic valve implantation

Stortecky S, Schmid V, Windecker S, Kadner A, Pilgrim T, Buellesfeld L, Khattab A, Wenaweser P

free

10.4244/EIJV8I4A70 • Aug 24, 2012

Comparison of two drug-eluting balloons: a report from the SCAAR registry

Bondesson P, Lagerqvist B, James S, Olivecrona G, Venetsanos D, Harnek J

free

10.4244/EIJV8I4A71 • Aug 24, 2012

Paclitaxel-coated balloon plus bare metal stent vs. sirolimus-eluting stent in de novo lesions: an IVUS study

Fischer D, Scheller B, Schäfer A, Klein G, Böhm M, Clever Y, Cremers B

free

10.4244/EIJV8I4A72 • Aug 24, 2012

Culprit only or multivessel percutaneous coronary interventions in patients with ST-segment elevation myocardial infarction and multivessel disease

Jensen L, Thayssen P, Farkas D, Hougaard M, Terkelsen CJ, Tilsted H, Maeng M, Junker A, Lassen JF, Horv E, Sørensen H, Thuesen L

free

10.4244/EIJV8I4A73 • Aug 24, 2012

Contemporary use and outcome of percutaneous coronary interventions in patients with acute coronary syndromes: insights from the 2010 ACSIS and ACSIS-PCI surveys

Segev A, Matetzky S, Danenberg H, Fefer P, Bubyr L, Zahger D, Roguin A, Gottlieb S, Kornowski R

free

10.4244/EIJV8I4A74 • Aug 24, 2012

De Luca G, Gibson CM, Huber K, Dudek D, Cutlip D, Zeymer U, Gyöngyösi M, Bellandi F, Noc M, Arntz H-R, Maioli M, Secco G, Zorman S, Gabriel H, Emre A, Rakowski T, van 't Hof AW

free

10.4244/EIJV8I4A75 • Aug 24, 2012

Optical coherence tomography assessment of the spatial distribution of culprit ruptured plaques and thin-cap fibroatheromas in acute coronary syndrome

Toutouzas K, Karanasos A, Riga M, Tsiamis E, Synetos A, Michelongona A, Papanikolaou A, Triantafyllou G, Tsioufis K, Stefanadis C

free

10.4244/EIJV8I4A76 • Aug 24, 2012

Bivalirudin versus unfractionated heparin in percutaneous coronary interventions of patients having received initial fondaparinux treatment: a propensity matched study

Hamon M, Rao SV, Steg G, Valgimigli M, Verheugt F, Marso S, Gershlick A, Wang Y, Deliargyris E

free

10.4244/EIJV8I4A77 • Aug 24, 2012

Vasomotor function and re-endothelialisation after implantation of biodegradable abluminal polymer coated paclitaxel-eluting stents in rabbit iliac arteries: a time-course study

Nakamura T, Winsor-Hines D, Yin X, Sushkova N, Chen J, King S, Chronos N, Eppihimer M, Huibregtse B, Dawkins K, Hou D

free

10.4244/EIJV8I4A78 • Aug 24, 2012

The transradial versus the transfemoral approach for primary percutaneous coronary intervention in patients with acute myocardial infarction: a systematic review and meta-analysis

Jang J, Jin H, Seo J, Yang T-H, Kim D-K, Kim D-K, Kim D-I, Cho K-I, Kim B-H, Park Y, Je H-G, Kim D-S

free